Name | 1-{2-[2-Chloro-4-(2H-1,2,3-triazol-2-yl)benzyl]-2,7-diazaspiro[3.5]non-7-yl}-2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)ethanone |
---|---|
Synonyms |
1-{2-[2-Chloro-4-(2H-1,2,3-triazol-2-yl)benzyl]-2,7-diazaspiro[3.5]non-7-yl}-2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)ethanone
Ethanone, 1-[2-[[2-chloro-4-(2H-1,2,3-triazol-2-yl)phenyl]methyl]-2,7-diazaspiro[3.5]non-7-yl]-2-(2-methylimidazo[2,1-b]thiazol-6-yl)- |
Description | PF-04628935 (compound 10n) is a potent ghrelin receptor inverse agonist, with an IC50 of 4.6 nM. PF-04628935 exhibits oral bioavailability of 43% in rats and shows reasonable penetration into the brain. PF-04628935 can be used for stress and anxiety research[1][2]. |
---|---|
Related Catalog | |
Target |
GHSR1a:4.6 nM (IC50) |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C24H26ClN7OS |
Molecular Weight | 496.03 |
Exact Mass | 495.160797 |
LogP | 4.14 |
Index of Refraction | 1.764 |
RIDADR | NONH for all modes of transport |
---|